Thank you to everyone who has participated in the project. We continue to analyze and share the data generated through your partnership, which will help shape the future of research in esophageal and stomach cancers.

Count Me In remains committed to elevating patient centered research, revolutionizing the understanding of rare cancers and rare diseases, accelerate treatment discovery, and driving medical progress.